Results 191 to 200 of about 3,186,450 (234)
Improvements in Health‐Related Quality of Life With Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial
Arthritis Care &Research, EarlyView.Objective
Although treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL ...Austin Barry, Bryant R. England, Harlan Sayles, Lindsay N. Helget, Maria Androsenko, Hongsheng Wu, Kaleb Michaud, Bridget Kramer, Jeff A. Newcomb, Mary T. Brophy, Anne Davis‐Karim, Ryan Ferguson, Michael H. Pillinger, Tuhina Neogi, Paul M. Palevsky, James R. O'Dell, Ted R. Mikuls +16 morewiley +1 more sourceClinical characteristics of Graves' disease following COVID-19 infection or vaccination: a multicenter case-control study. [PDF]
Turk J Med SciGökçay Canpolat A, Ağbaht K, Elhan AH, Cesur M, Alphan Üç Z, Akçay S, Iliksu Gözü H, Aşik M, Bostan H, Uçan B, Şah Ünal T, Yilmaz M, Kubat Üzüm A, Ünal MÇ, Anil C, Mutlu Ü, Ince N, Faki S, Cansu GB, Ertürk MS, Oğuz A, Aydemir M, Polat ŞB, Topaloğlu O, Ersoy R, Çakir B, Ok AM, Karakiliç E, Yalçin M, Kayhan Y, Uğur K, Yazici D, Gürlek A, Omma T, Saygili ES, Batman A, Kara B, Yorulmaz G, Evren B, Baloş Törüner F, Yildiz BO, Erdoğan MF, Alagöl F, Çakal E, Şahin M. +44 moreeuropepmc +1 more sourceMonocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis–Associated Interstitial Lung Disease
Arthritis Care &Research, EarlyView.Objective
A leading cause of death among patients with scleroderma (SSc), interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.Cristina M. Padilla, Robert Lafyatis, Kevin F. Gibson, Christina Morse, Eleanor Valenzi, Xiaoping Chen, Xiaoyun Li, Yanwu Zhao, Yongseok Park, Dana Ascherman, Jonathan Minden, Robyn Domsic, Yingze Zhang, Daniel J. Kass +13 morewiley +1 more sourceHeterogeneity of Rheumatoid Arthritis–Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations With Disease Outcomes
Arthritis Care &Research, EarlyView.Objective
We aimed to identify unique disease trajectories within rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods
We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999 to 2021.Bryant R. England, Yangyuna Yang, Punyasha Roul, Tate M. Johnson, Scott M. Matson, Grant W. Cannon, Brian C. Sauer, Jeffrey R. Curtis, Joshua F. Baker, Ted R. Mikuls +9 morewiley +1 more sourceReal-World Effectiveness of Seasonal Influenza Vaccines During the 2024-2025 Season: Subgroup Analyses by Virus Subtype, Time Since Vaccination, and Diagnostic Method. [PDF]
Vaccines (Basel)Choi YJ, Lee J, Song JY, Wie SH, Lee J, Lee JS, Jeong HW, Eom JS, Sohn JW, Yoon YK, Choi WS, Nham E, Yoon JG, Noh JY, Park MS, Cheong HJ. +15 moreeuropepmc +1 more sourceSerum Uric Acid Levels in Older Adults: Associations With Clinical Outcomes and Implications for Reference Intervals in Those Aged 70 Years and Over
Arthritis Care &Research, EarlyView.Objective
Reports have linked both high and low serum uric acid (SUA) levels to adverse health outcomes. This study aimed to establish a reference interval for SUA in older adults and assessed its association with clinically relevant outcomes in relatively healthy, community‐dwelling individuals aged ≥70 years old.Amanda J. Rickard, Cammie Tran, Hans G. Schneider, Flavia M. Cicuttini, Anita E. Wluka, Ego Seeman, Johannes T. Neumann, Md Nazmul Karim, Zhen Zhou, Sultana Monira Hussain, David P. Q. Clark, Daniel Clayton‐Chubb, Andrew M. Tonkin, Lawrence J. Beilin, Robyn L. Woods, John J. McNeil +15 morewiley +1 more sourceLong‐Term Opioids in Gout: A Matched Cohort Study From the Veterans Health Administration
Arthritis Care &Research, EarlyView.Objective
Though used frequently to treat flare, risk of long‐term opioid exposure in gout has not been well defined. In this study, we examined the hypothesis that people with gout are more likely than individuals without gout to be prescribed long‐term opioids over time.Lindsay N. Helget, Bryant R. England, Punyasha Roul, Harlan Sayles, Tuhina Neogi, James R. O'Dell, Joshua F. Baker, Ted R. Mikuls +7 morewiley +1 more sourceUnfolding dermatological spectrum of Still's disease: a cohort study from the International AIDA Network Still's Disease Registry. [PDF]
Rheumatology (Oxford)Calabrese L, D'Onghia M, Cartocci A, Hinojosa-Azaola A, Torres-Ruiz J, Lopalco G, Sbalchiero J, Caggiano V, Giardini HAM, Almaghlouth IA, Ruscitti P, Di Cola I, Sfikakis PP, Laskari K, Sfriso P, Dagna L, Campochiaro C, Tufan A, Kucuk H, Kardas RC, Erden A, Ragab G, Hegazy MT, Laymouna AH, Navarini L, Berardicurti O, Ciccia F, Iacono D, Riccio F, Fotis L, Direskeneli H, Makowska J, Iagnocco A, Conforti A, Rigante D, Thabet M, Iannone F, Domanico D, Govoni M, Maggio MC, Del Giudice E, La Torre F, Batu ED, Ozen S, Gaggiano C, Martín-Nares E, Guaracha-Basañez GA, Karamanakos A, Lo Gullo A, Monosi B, Bartoloni E, Hernández-Rodríguez J, Gómez-Caverzaschi V, Emmi G, Erten S, Carubbi F, Gicchino MF, De Paulis A, Conti G, Ogunjimi B, Wiesik-Szewczyk E, Nowakowska-Płaza A, Viapiana O, Sarzi-Puttini P, Tharwat S, Crisafulli F, Parronchi P, Gidaro A, De Stefano L, Breda L, La Barbera L, Guggino G, Balistreri A, Fabiani C, Rubegni P, Frediani B, Giacomelli R, Cantarini L, Vitale A, International AIDA (AutoInflammatory Diseases Alliance) Network and the Autoinflammatory Diseases Working Group of the Italian Society of Rheumatology (SIR)
. +79 moreeuropepmc +1 more source